194 related articles for article (PubMed ID: 15256057)
1. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
[TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
5. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
6. Genistein versus ICI 182, 780: an ally or enemy in metastatic progression of prostate cancer.
Nakamura H; Wang Y; Xue H; Romanish MT; Mager DL; Helgason CD; Wang Y
Prostate; 2013 Dec; 73(16):1747-60. PubMed ID: 24038102
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.
Yonou H; Kanomata N; Goya M; Kamijo T; Yokose T; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2003 May; 63(9):2096-102. PubMed ID: 12727825
[TBL] [Abstract][Full Text] [Related]
8. MEK4 function, genistein treatment, and invasion of human prostate cancer cells.
Xu L; Ding Y; Catalona WJ; Yang XJ; Anderson WF; Jovanovic B; Wellman K; Killmer J; Huang X; Scheidt KA; Montgomery RB; Bergan RC
J Natl Cancer Inst; 2009 Aug; 101(16):1141-55. PubMed ID: 19638505
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein.
Li Y; Sarkar FH
Cancer Lett; 2002 Dec; 186(2):157-64. PubMed ID: 12213285
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of genistein-treated PC3 prostate cancer cells.
Li Y; Sarkar FH
J Nutr; 2002 Dec; 132(12):3623-31. PubMed ID: 12468598
[TBL] [Abstract][Full Text] [Related]
11. Dietary genistein inhibits metastasis of human prostate cancer in mice.
Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC
Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885
[TBL] [Abstract][Full Text] [Related]
12. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.
Dong Z; Bonfil RD; Chinni S; Deng X; Trindade Filho JC; Bernardo M; Vaishampayan U; Che M; Sloane BF; Sheng S; Fridman R; Cher ML
Am J Pathol; 2005 Apr; 166(4):1173-86. PubMed ID: 15793297
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors.
Goya M; Miyamoto S; Nagai K; Ohki Y; Nakamura K; Shitara K; Maeda H; Sangai T; Kodama K; Endoh Y; Ishii G; Hasebe T; Yonou H; Hatano T; Ogawa Y; Ochiai A
Cancer Res; 2004 Sep; 64(17):6252-8. PubMed ID: 15342412
[TBL] [Abstract][Full Text] [Related]
17. Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.
Pitchakarn P; Suzuki S; Ogawa K; Pompimon W; Takahashi S; Asamoto M; Limtrakul P; Shirai T
Food Chem Toxicol; 2012 Mar; 50(3-4):840-7. PubMed ID: 22266361
[TBL] [Abstract][Full Text] [Related]
18. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of human fetal bone implants in SCID mice as a model of prostate cancer bone metastasis.
Singh AS; Macpherson GR; Price DK; Schimel D; Figg WD
Oncol Rep; 2006 Mar; 15(3):519-24. PubMed ID: 16465406
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
Wang Y; Raffoul JJ; Che M; Doerge DR; Joiner MC; Kucuk O; Sarkar FH; Hillman GG
Radiat Res; 2006 Jul; 166(1 Pt 1):73-80. PubMed ID: 16808622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
